Literature DB >> 12353268

Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.

Marie-Joëlle Mozziconacci1, Angelika Rosenauer, Audrey Restouin, Mirco Fanelli, Wenlin Shao, Francisca Fernandez, Yves Toiron, Jeanine Viscardi, Carlo Gambacorti-Passerini, Wilson H Miller, Marina Lafage-Pochitaloff.   

Abstract

The retinoic acid (RA)-sensitive NB4 cell line was the first established acute promyelocytic leukemia (APL) permanent cell line. It harbors the (15;17) translocation, which fuses the PML and RARA genes. Given the low frequency of APLs, their generally low white blood cell count, and the difficulty to work on APL patient cells, this cell line represents a remarkable tool for biomolecular studies. To investigate possible mechanisms of retinoid resistance, subclones of NB4 resistant to all-trans retinoic acid (ATRA) were established. To characterize better the parental NB4 cell line and four ATRA-resistant subclones (NB4-R4, NB4-A1, NB4-B1, and NB4-007/6), we have performed both conventional and 24-color FISH karyotyping. Thus, we could identify all chromosomal abnormalities including marker chromosomes that were unclassified with R banding. Moreover, we have performed dual-color FISH by use of specific PML and RARA probes, to evaluate the number of copies for each gene and fusion gene. Interestingly, the number of copies of PML, RARA, and fusion genes was different for each cell line. Finally, we assessed the presence of the PML, RARA, PML/RARA, and RARA/PML transcripts by RT-PCR and of the PML/RARA and RARA proteins by Western blotting in all the cell lines. These data could focus further research for a better understanding of the molecular mechanisms underlying response or resistance to differentiating and/or apoptotic reagents. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353268     DOI: 10.1002/gcc.10117

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.

Authors:  Marjan Yaghmaie; Hossein Mozdarani; Kamran Alimoghaddam; Seyed Hamidullah Ghaffari; Ardeshir Ghavamzadeh; Marjan Hajhashemi
Journal:  Med Oncol       Date:  2011-05-05       Impact factor: 3.064

2.  Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.

Authors:  Tadayuki Akagi; Lee-Yung Shih; Motohiro Kato; Norihiko Kawamata; Go Yamamoto; Masashi Sanada; Ryoko Okamoto; Carl W Miller; Der-Cherng Liang; Seishi Ogawa; H Phillip Koeffler
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

3.  Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.

Authors:  Elisabeth K M Mack; André Marquardt; Danny Langer; Petra Ross; Alfred Ultsch; Michael G Kiehl; Hildegard I D Mack; Torsten Haferlach; Andreas Neubauer; Cornelia Brendel
Journal:  Haematologica       Date:  2018-09-06       Impact factor: 9.941

Review 4.  Studying Neutrophil Function in vitro: Cell Models and Environmental Factors.

Authors:  Marfa Blanter; Mieke Gouwy; Sofie Struyf
Journal:  J Inflamm Res       Date:  2021-01-20

Review 5.  Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.

Authors:  Elise Aasebø; Rakel B Forthun; Frode Berven; Frode Selheim; Maria Hernandez-Valladares
Journal:  Curr Pharm Biotechnol       Date:  2016       Impact factor: 2.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.